PHARMACY

Indivior gets FDA nod for Perseris

BY Sandra Levy

The Food and Drug Administration has given the OK for Indivior’s Perseris (risperidone) for extended-release injectable suspension for the treatment of schizophrenia in adults.

Perseris contains risperidone, a well-established medicine for schizophrenia, and uses an extended-release delivery system to form a subcutaneous depot that provides sustained levels of risperidone over one month.

“The availability of Perseris provides physicians with a new treatment option to help address some of the challenges in treating schizophrenia,” Indivior’s CEO Shaun Thaxter said. “We understand the complex patient journey of people living with schizophrenia and recognize the important role that long-acting injectables can play. Perseris is a demonstration of our ongoing commitment to developing innovative treatments for people living with this debilitating condition.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
generic Trisenox
PHARMACY

Nexus gets FDA nod for generic Trisenox

BY Sandra Levy

Nexus Pharmaceuticals has received the Food and Drug Administration’s blessing for arsenic trioxide injection, a generic version of Teva’s Trisenox.

The generic Trisenox, which is available in 10 mg per 10 mL vial for injection, is indicated for relapsed or refractory acute promyelocytic leukemia.

“The approval of generic arsenic trioxide injection continues to show Nexus’s commitment in providing access to affordable critical-need generic injectables,” Nexus chief commercial officer Omair Ahmed said. “Collectively, as drug manufacturers and healthcare providers, we have a commitment to patients to ensure they are receiving affordable drugs they need, when they need them, which is why we make it our highest priority to be a reliable partner in supplying critical-need drugs.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FamilyWize updates prescription discount mobile app

BY Sandra Levy

FamilyWize, an organization that offers families and individuals access to their medications at a more affordable cost, has significantly enhanced its mobile app’s overall design and performance capabilities to save time and money for its users.

Available to all smartphone users via the iOS App Store and Google Play, the updated FamilyWize app features an improved Medicine Cabinet tool, enabling users to more easily find, manage and compare drug costs to save on their prescription medications. Medicine Cabinet users can update their dosages and preferred pharmacy location if a lower price is found elsewhere.

The update also unifies FamilyWize’s mobile app with its website to best serve its users. New features include the ability to view a saved medication’s price upon opening the app, which helps a user decide where to refill by alerting them if lower prices are available, or if they already have the best FamilyWize price.

Additional features include Medication History, which stores a list of active and past medications; and Saved Pharmacies, which automatically catalogs all bookmarked pharmacies into a concise list and allows users to receive notifications at local pharmacies.

“Today’s customer, whether purchasing clothes or prescription medications, values immediacy, consistency and simplicity, so we are constantly streamlining our operations to meet their needs,” FamilyWize director of marketing Mike Carollo said. “The FamilyWize mobile app now makes managing and saving money on medications even easier for our users, and we strive to be the most useful resource in the ongoing fight to lower one’s drug costs.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?